Kevin Joseph Fitzgerald

Kevin Joseph Fitzgerald

EVP · ALNYLAM PHARMACEUTICALS, INC.

Rank #11,115 SEC EDGAR (United States) ↗ Files from United States

Details

Officer and board memberPharmaceuticals & BiotechnologyALNYSEC CIK 0001886431

Computed from SEC EDGAR filings and closing prices — not copied from any wealth ranking. Dataset . How we calculate this.

Disclosed holdings
$5.6M
1-day change
▲ 0.61%
Positions on file
1
issuers disclosed in Forms 3/4/5 and Schedules 13D/G

Disclosed holdings over time 53 weekly points

What the 1 currently disclosed position would have been worth at each week’s closing price. A rising line means the shares got more valuable, not that this person bought more.

How the line is built

Share counts are as last reported to the SEC and held constant; only prices move.

2025-09-05$4.3M – $10.2M2026-09-04

Insider activity Jun 24, 2024 – Mar 5, 2026

Kevin Joseph Fitzgerald is recorded in filings to the U.S. SEC via EDGAR as officer and board member, and reported 167 transactions between Jun 24, 2024 and Mar 5, 2026. The buy and sell totals below count only codes P, S.

Why the other codes are excluded

Share awards (A), shares withheld to pay tax (F), option exercises (M) and gifts (G) also appear in the table, but they are consequences of a pay package or a private transfer, not a decision to buy or sell on the open market. Counting them would turn this into a compensation ranking.

Open-market buys (code P)
None
0 purchases on file
Open-market sales (code S)
$19.69M
152 sales on file priced rows only
All reported transactions
167
every code, including awards and exercises
Pattern
Net seller in the final 12 months of the window
last 12 months of the window

Events from filings

Detected automatically in the filings linked below. Each headline is built from the numbers in those filings, not written by a model. Newest first; events older than 45 days stay listed and are marked as older.

Kevin Joseph Fitzgerald sold 2,041 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $677,530 on Feb 17, 2026

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Kevin Joseph Fitzgerald sold 2,041 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $677,530 on Feb 17, 2026
Date Insider Transaction Shares Price Value Filing
Feb 17, 2026 Kevin Joseph Fitzgerald S Open-market sale 2,041 held after: 21,264 $331.96 $677,530 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Kevin Joseph Fitzgerald sold 1,959 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $607,447 on Feb 13, 2026

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Kevin Joseph Fitzgerald sold 1,959 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $607,447 on Feb 13, 2026
Date Insider Transaction Shares Price Value Filing
Feb 13, 2026 Kevin Joseph Fitzgerald S Open-market sale 1,959 held after: 23,305 $310.08 $607,447 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Kevin Joseph Fitzgerald sold 8,168 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $3,667,432 on Nov 17, 2025

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Kevin Joseph Fitzgerald sold 8,168 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $3,667,432 on Nov 17, 2025
Date Insider Transaction Shares Price Value Filing
Nov 17, 2025 Kevin Joseph Fitzgerald S Open-market sale 8,168 held after: 25,224 $449.00 $3,667,432 SEC filing ↗

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Kevin Joseph Fitzgerald sold 20,732 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $5,614,459 on Aug 12, 2024

Large trade for this person

Flagged because this trade was large compared with this person’s own earlier open-market trades in the same currency — not because it is large in absolute terms. A trade that is routine for one insider can be flagged for another.

Kevin Joseph Fitzgerald sold 20,732 ALNYLAM PHARMACEUTICALS, INC. (ALNY) shares for $5,614,459 on Aug 12, 2024
Date Insider Transaction Shares Price Value Filing
Aug 12, 2024 Kevin Joseph Fitzgerald S Open-market sale 1,421 held after: 33,485 $268.66 $381,766 SEC filing ↗
Aug 12, 2024 Kevin Joseph Fitzgerald S Open-market sale 9,662 held after: 23,823 $270.17 $2,610,383 SEC filing ↗
Aug 12, 2024 Kevin Joseph Fitzgerald S Open-market sale 5,736 held after: 18,087 $271.32 $1,556,292 SEC filing ↗
Aug 12, 2024 Kevin Joseph Fitzgerald S Open-market sale 3,913 held after: 14,174 $272.43 $1,066,019 SEC filing ↗

Total of the rows above: $5,614,459, in the currency the filings report.

Source: SEC EDGAR (United States); every row links to where it was published. Event computed Sep 14, 2026.

Reported transactions

Price 0.00 is a real reported figure on gifts (G) and share awards (A) — not a missing number. The 25 most recent rows are grouped into 6 lines by date, company and transaction type — open a line to see every lot with its own source link. We hold 168 on file in total. See the full history on EDGAR ↗

How to read this list

Every row is one line of one Form 4 or Form 5, with the filing it came from. Where the record carries no price at all we leave the cell empty instead of guessing one.

The shares and money on a grouped line add up only the lots listed inside that line, and only when every one of them carries the figure. Where a group mixes more than one reporting currency we leave the money blank rather than convert — no source publishes the rate that conversion would need.

  1. Ovid Therapeutics Inc. OVID A Grant or awardnot a buy/sell decision 17,578 shares $45.0K at $2.56 SEC filing ↗
  2. ALNYLAM PHARMACEUTICALS, INC. ALNY S Open-market sale × 4 658 shares $213.2K
    The 4 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    153 $326.24 $49.9K SEC filing ↗
    148 $324.60 $48.0K SEC filing ↗
    233 $323.25 $75.3K SEC filing ↗
    124 $321.81 $39.9K SEC filing ↗
  3. ALNYLAM PHARMACEUTICALS, INC. ALNY S Open-market sale × 8 633 shares $204.5K
    The 8 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    59 $320.81 $18.9K SEC filing ↗
    79 $321.82 $25.4K SEC filing ↗
    28 $320.01 $9.0K SEC filing ↗
    57 $325.67 $18.6K SEC filing ↗
    75 $324.88 $24.4K SEC filing ↗
    210 $323.84 $68.0K SEC filing ↗
    96 $323.01 $31.0K SEC filing ↗
    29 $319.03 $9.3K SEC filing ↗
  4. ALNYLAM PHARMACEUTICALS, INC. ALNY S Open-market sale × 4 1,652 shares $528.2K
    The 4 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    359 $321.58 $115.4K SEC filing ↗
    722 $320.51 $231.4K SEC filing ↗
    282 $318.62 $89.9K SEC filing ↗
    289 $316.55 $91.5K SEC filing ↗
  5. ALNYLAM PHARMACEUTICALS, INC. ALNY A Grant or awardnot a buy/sell decisionreported at zero 3,688 shares $0 at $0.00 SEC filing ↗
  6. ALNYLAM PHARMACEUTICALS, INC. ALNY S Open-market sale × 7 1,386 shares $453.3K
    The 7 lots that make up this line, each with the source behind it.
    Shares Price Value Filing
    47 $323.62 $15.2K SEC filing ↗
    90 $324.65 $29.2K SEC filing ↗
    258 $325.63 $84.0K SEC filing ↗
    392 $326.81 $128.1K SEC filing ↗
    329 $327.67 $107.8K SEC filing ↗
    100 $328.71 $32.9K SEC filing ↗
    170 $329.71 $56.1K SEC filing ↗

Disclosed holdings

Shares is the amount on the form; value is that amount times the closing price shown. Rows with no closing price are left blank, so they may add up to less than the headline figure.

What is not counted here

Each row is one filing you can open. Private companies, real estate, bonds and crypto are not in SEC insider filings and are therefore not counted here.

Equity positions disclosed to the SEC, with the source filing behind each row.
Issuer Ticker Security Shares Close Value Form Reported Filing
ALNYLAM PHARMACEUTICALS, INC. ALNY Common Stock 21,106 $266.11 $5.6M 4 EDGAR ↗

Other insiders at the same companies

People who also file with the SEC at a company where Kevin Joseph Fitzgerald reports shares.

Sharing a filing does not mean they work together day to day — it means both names appear on the same issuer’s insider record.

Sources

The filings linked in the tables above are the sources for every figure on this page.

Portrait photograph: ALNYLAM PHARMACEUTICALS, INC. (company-published photograph). Original file page on alnylam.com ↗

Think a number here is wrong? Open the linked filing and compare — how to report it.

Profile record last refreshed Sep 8, 2026.

Logo credits

Logo credits. Logos on this page are shown to identify the company they belong to; trademarks remain the property of their owner. Files whose licence requires naming the author are listed here. Logos in the public domain or released under CC0 are not listed, because those licences ask for nothing.

ALNYLAM PHARMACEUTICALS, INC.: Alnylam Pharmaceuticals / CC BY-SA 3.0, via Wikimedia Commons ↗